Methodology Issues in a Tailored Light Treatment for Persons With Dementia - Aim 2

Completed · Not applicable

Conditions studied: Alzheimer's Disease, Sleep Disturbance

In brief

Aim 2 will investigate the effect of 3 different light exposure lengths on sleep, mood and agitation in persons with Alzheimer's disease. Participants will be randomly assigned to one of three conditions of light exposure: 1) 2-h morning light exposure; 2) 4-h morning light exposure; and 3) all day light exposure.

Key facts

Study ID

NCT05837819

Run by

Icahn School of Medicine at Mount Sinai

People needed

135

Starts

2023-02-14

Expected to finish

2025-07-31

Last updated by the study team

2026-06-01

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of Alzheimer's disease or related dementia with a Montreal Cognitive Assessment score <25
• Sleep disturbance with a Pittsburgh Sleep Quality Index score ≥5

You may not qualify if…

• Extensive brain vascular disease, traumatic brain injury, multiple sclerosis, Parkinson's Disease
• Obstructing cataracts
• Severe macular degeneration
• Use of sleep medication
• Use of oral melatonin
• untreated moderate to severe sleep apnea
• Severe restless leg syndrome
• Blindness

Where it is running

• Icahn School of Medicine at Mount Sinai — Albany, New York, United States
• Icahn School of Medicine at Mount Sinai — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.